Ventyx Biosciences, Inc.
VTYX
$7.94
-$1.44-15.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.43% | -1.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.20% | -2.54% | |||
| Operating Income | 15.20% | 2.54% | |||
| Income Before Tax | 15.41% | 1.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.41% | 1.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.41% | 1.65% | |||
| EBIT | 15.20% | 2.54% | |||
| EBITDA | 15.22% | 2.42% | |||
| EPS Basic | 15.51% | 1.76% | |||
| Normalized Basic EPS | 15.53% | 1.74% | |||
| EPS Diluted | 15.51% | 1.76% | |||
| Normalized Diluted EPS | 15.53% | 1.74% | |||
| Average Basic Shares Outstanding | 0.15% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||